Profiel
Robert Paul formerly worked at Nine Square Therapeutics, Inc., as Chief Executive Officer from 2022 to 2025, Genentech, Inc., as Assistant Director-Group Medical from 2015 to 2016, and Alector, Inc., as Chief Medical Officer from 2016 to 2021.
Dr. Paul received his doctorate degree from Ludwig-Maximilians-Universität München.
Eerdere bekende functies van Robert Paul
| Bedrijven | Functie | Einde |
|---|---|---|
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Algemeen Directeur | 01-02-2025 |
| ALECTOR, INC. | Hoofd Techniek/Wetenschap/O&O | 11-10-2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-10-2016 |
Opleiding van Robert Paul
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
















